Search research articles
Contact Us
Filters
Showing results (41-50 of 234) with videos related to
Page
of 24
Sort By:
Current Topics in Medicinal Chemistry
|
December 27, 2011
RNA interference-mediated validation of survivin and Apollon/BRUCE as new therapeutic targets for cancer therapy
Marzia Pennati, Enrico Millo, Paolo Gandellini, et al.
BMC Cancer
|
June 8, 2010
Prognostic relevance of ALT-associated markers in liposarcoma: a comparative analysis
Lorenza Venturini, Rosita Motta, Alessandro Gronchi, et al.
Current Medicinal Chemistry
|
February 16, 2013
MicroRNA-mediated control of prostate cancer metastasis: implications for the identification of novel biomarkers and therapeutic targets
Nicola Fenderico, Anna Casamichele, Valentina Profumo, et al.
Current Treatment Options in Oncology
|
April 14, 2023
New Molecular Insights, and the Role of Systemic Therapies and Collaboration for Treatment of Epithelioid Hemangioendothelioma (EHE)
Silvia Stacchiotti, William Tap, Hugh Leonard, et al.
Current Pharmaceutical Design
|
July 1, 2014
MicroRNA-dependent regulation of telomere maintenance mechanisms: a field as much unexplored as potentially promising
Francesca Santambrogio, Paolo Gandellini, Graziella Cimino-Reale, et al.
Oncotarget
|
April 1, 2015
PLK1 is a critical determinant of tumor cell sensitivity to CPT11 and its inhibition enhances the drug antitumor efficacy in squamous cell carcinoma models sensitive and resistant to camptothecins
Valentina Zuco, Michelandrea De Cesare, Nadia Zaffaroni, et al.
Current Pharmaceutical Design
|
September 15, 2012
Modulation of sensitivity to antitumor agents by targeting the MAPK survival pathway
Giacomo Cossa, Laura Gatti, Giuliana Cassinelli, et al.
Cell Cycle (Georgetown, Tex.)
|
September 8, 2011
Characterization of novel antisense HIF-1α transcripts in human cancers
Davide Bertozzi, Raffaella Iurlaro, Olivier Sordet, et al.
Cell Proliferation
|
September 14, 2021
δ-Tocotrienol sensitizes and re-sensitizes ovarian cancer cells to cisplatin via induction of G1 phase cell cycle arrest and ROS/MAPK-mediated apoptosis
Fabrizio Fontana, Monica Marzagalli, Michela Raimondi, et al.
Current Medicinal Chemistry
|
April 7, 2016
Role of the Receptor Tyrosine Kinase Axl and its Targeting in Cancer Cells
Cristina Corno, Laura Gatti, Cinzia Lanzi, et al.
Page
of 24
Search research articles
Search
Showing results (41-50 of 234) with videos related to
Sort By:
Page
of 24
Current Topics in Medicinal Chemistry
|
December 27, 2011
RNA interference-mediated validation of survivin and Apollon/BRUCE as new therapeutic targets for cancer therapy
Marzia Pennati, Enrico Millo, Paolo Gandellini, et al.
BMC Cancer
|
June 8, 2010
Prognostic relevance of ALT-associated markers in liposarcoma: a comparative analysis
Lorenza Venturini, Rosita Motta, Alessandro Gronchi, et al.
Current Medicinal Chemistry
|
February 16, 2013
MicroRNA-mediated control of prostate cancer metastasis: implications for the identification of novel biomarkers and therapeutic targets
Nicola Fenderico, Anna Casamichele, Valentina Profumo, et al.
Current Treatment Options in Oncology
|
April 14, 2023
New Molecular Insights, and the Role of Systemic Therapies and Collaboration for Treatment of Epithelioid Hemangioendothelioma (EHE)
Silvia Stacchiotti, William Tap, Hugh Leonard, et al.
Current Pharmaceutical Design
|
July 1, 2014
MicroRNA-dependent regulation of telomere maintenance mechanisms: a field as much unexplored as potentially promising
Francesca Santambrogio, Paolo Gandellini, Graziella Cimino-Reale, et al.
Oncotarget
|
April 1, 2015
PLK1 is a critical determinant of tumor cell sensitivity to CPT11 and its inhibition enhances the drug antitumor efficacy in squamous cell carcinoma models sensitive and resistant to camptothecins
Valentina Zuco, Michelandrea De Cesare, Nadia Zaffaroni, et al.
Current Pharmaceutical Design
|
September 15, 2012
Modulation of sensitivity to antitumor agents by targeting the MAPK survival pathway
Giacomo Cossa, Laura Gatti, Giuliana Cassinelli, et al.
Cell Cycle (Georgetown, Tex.)
|
September 8, 2011
Characterization of novel antisense HIF-1α transcripts in human cancers
Davide Bertozzi, Raffaella Iurlaro, Olivier Sordet, et al.
Cell Proliferation
|
September 14, 2021
δ-Tocotrienol sensitizes and re-sensitizes ovarian cancer cells to cisplatin via induction of G1 phase cell cycle arrest and ROS/MAPK-mediated apoptosis
Fabrizio Fontana, Monica Marzagalli, Michela Raimondi, et al.
Current Medicinal Chemistry
|
April 7, 2016
Role of the Receptor Tyrosine Kinase Axl and its Targeting in Cancer Cells
Cristina Corno, Laura Gatti, Cinzia Lanzi, et al.
Page
of 24